CN101491835A - Preparation method of heparin modified gold nano-particles - Google Patents
Preparation method of heparin modified gold nano-particles Download PDFInfo
- Publication number
- CN101491835A CN101491835A CNA2009100248434A CN200910024843A CN101491835A CN 101491835 A CN101491835 A CN 101491835A CN A2009100248434 A CNA2009100248434 A CN A2009100248434A CN 200910024843 A CN200910024843 A CN 200910024843A CN 101491835 A CN101491835 A CN 101491835A
- Authority
- CN
- China
- Prior art keywords
- solution
- molecular weight
- low molecular
- weight heparin
- heparin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention belongs to the field of nano diagnosis, in particular to a method for preparing heparin-modified gold nano particles. The method for preparing the heparin-modified gold nano particles is to add low molecular weight heparin into a gold nano particle solution which is reduced by a reducing agent, and obtain the gold nano particles which are modified by the low molecular weight heparin, wherein the low molecular weight heparin is hydrosulphonyl-containing low molecular weight heparin, and the reducing agent is sodium borohydride or sodium citrate. The method adopts the hydrosulphonyl-containing low molecular weight heparin as a modifier to stabilize gold nano particles which are prepared by taking the sodium borohydride or the sodium citrate as the reducing agent, and obtains the gold nano particles with small particle diameter and uniform distribution by controlling the proportion of the hydrosulphonyl-containing low molecular weight heparin and the sodium borohydride or the sodium citrate. Moreover, the method can be applied to detection of proteins or viruses, and has the advantages of quickness and convenience compared with other virus detection methods such as an immunological method and PCR polymerase chain reaction. The invention provides a novel method for industrialized production for quick virus detection.
Description
Technical field
The invention belongs to field of nano diagnosis, relate to a kind of method for preparing heparin-modified gold nano particles, be particularly related to a kind of low molecular weight heparin of band sulfydryl that utilizes and be trim, sodium borohydride or natrium citricum are the method that reducing agent prepares heparin-modified gold nano particles.
Background technology
In recent years, along with the rise of nanosecond science and technology, golden nanometer particle surface self assembly has been subjected to paying close attention to widely, and the gold particle of nanoscale shows potential using value in a lot of fields with its unique character, has caused the research interest that people are dense.Golden nanometer particle is the most stable metal nanoparticle, the gold particle of nanoscale has the character of unique, relevant with size aspects such as optics, calorifics, electricity, magnetics and chemistry: absorb (SPR) as surface plasmon resonance, Raman scattering (RS), and high catalytic activity, biocompatibility and stability etc.These characteristics make golden nanometer particle (GNPs) have important use at aspects such as analysis, catalysis, photoelectric device, biology sensor, biomedicines.
Mammiferous cell surface has the carbohydrate of the intensive glycocalix of one deck, and these compounds and physiology and pathological research all have very big getting in touch, as: metabolism, inflammation infects etc.
Heparin (heparin) then is the Sulfated Heparan sulfate of a class height.Heparan sulfate is owing to have a large amount of negative electrical charges, be easy to and the protein of virus surface positively charged between produce nonspecific electrostatic interaction, thereby make virus be attached on cell surface, play an important role in the initial period of multiple poisoning intrusion cell.Comprise multiple flaviviridae in these viruses, as dengue fever virus (Dengue), typical case's hog cholera virus (classical swinefever, CSF), mite passes encephalitis viruses (tick-borne encephalitis viruses, TBE), herpes simplex virus 1 (herpes simplex virus 1), 8-type nerpes vinrus hominis (human herpesvirus 8) and papillomavirus (papilloma virus).Generally believe the motion of the interaction partners virus of virus surface molecule and Heparan sulfate and pathogenic considerable influence arranged.In addition, HS also can produce specificity with some virus surface proteins matter and interact, and participates in entering and course of infection of regulation and control virus directly.
The optical effect relevant based on the golden nanometer particle uniqueness with size, we can be connected to heparin the gold particle surface, the mechanism of action on analog cell surface, combine the characteristics of virus by heparin with combined with protein or specificity, thereby cause that the optical change that the gathering of golden nanometer particle causes detects virus.
At present, how modify golden nanometer particles, but the research of carbohydrate or sugar-modified golden nanometer particle is deep not enough with chemistry or biomolecule such as DNA, protein, polymer, dendrimer, dendritic polymer or functionalization sulfydryl etc.Existing research is modified golden nanometer particle with micromolecular monose or disaccharide unit mostly, and structure is single; The polysaccharide that perhaps adopts the method for positive and negative Electrostatic Absorption will have electric charge is adsorbed on nanoparticle surface.This static adhesion does not have the adhesion of chemical bond strong, is subjected to the influence of effects of ion easily, makes the nano particle instability of the polyose modification of formation.
Therefore, the present invention has prepared the low molecular weight heparin gold nano-particles modified of band sulfydryl, and the step of synthesizing nano-particle is simple to operation, and cost is low, and good stability, has remedied the deficiency of other sugar-modified golden nanometer particle methods.And can be used for the detection of virus and protein, the present invention has expanded new direction in field of nano diagnosis
Summary of the invention
The purpose of this invention is to provide a kind of method for preparing heparin-modified gold nano particles.
The method for preparing heparin-modified gold nano particles provided by the present invention is to be starting material with the heparin, at first uses HNO
2A certain proportion of Na is used in solution degradation then
2CO
3, H
2O, NaHCO
3Mixed solution be neutralized to neutrality, at NH
4HCO
3After the dialysis, freeze-drying obtains the low molecular weight heparin that reduction end is an aldehyde radical in the solution; Reduction end is the low molecular weight heparin of aldehyde radical and mercaptoethylmaine or p-Mercaptoaniline reaction, makees catalyst with sodium cyanoborohydride, adds the freeze-drying of dialysing after the thermal response, obtains the low molecular weight heparin with sulfydryl; In sodium borohydride or natrium citricum are the solution of gold nanoparticles of reducing agent reduction, add the low molecular weight heparin of band sulfydryl, obtain the golden nanometer particle of low molecular weight heparin as trim.
In the said method, the HNO of the described heparin that is used to degrade
2Solution was with 1: 1～1: 20 0.5M H
2SO
4With 5.5M NaNO
2The solution preparation, the reaction time is 0.5～4 hour, and reaction temperature is 0～10 ℃, and the solution that is used to neutralize is 1: 1: 1～1: 10: 10 1MNa
2CO
3, H
2O, 1MNaHCO
3Mixed solution, the NH that is used to dialyse
4HCO
3Solution concentration is 50mM.
In the said method, when reduction end is that the consumption of the low molecular weight heparin of aldehyde radical is when being 1g, the solvent that is used for the terminal low molecular weight heparin for aldehyde radical of dissolving and reducing is the phosphate buffer (pH7.0) of the 0.2M of 1～100ml, the consumption of mercaptoethylmaine or p-Mercaptoaniline is 0.1～1M, the consumption of described reaction system catalyst sodium cyanoborohydride is 1～2g, reaction time is 2～10 hours, and reaction temperature is 55～65 ℃.
In the said method, the concentration of the amount of substance of chlorauric acid solution is 1～5mM, the consumption of described borane reducing agent sodium hydride or natrium citricum is 0.01～0.1mM, the initial concentration of the low molecular weight heparin of described band sulfydryl is 0.1～10g, reaction time is 0.5～3 hour, and reaction temperature is 65～100 ℃.
The concrete steps of the preparation of a kind of heparin-modified gold nano particles provided by the invention are as follows: the heparin of 1g, and with 1: 1～1: 20 0.5MH
2SO
4With 5.5M NaNO
2Solution is mixed with 5mlHNO
2Solution degradation was reacted 0.5～4 hour down at 0～10 ℃, took normal jolting solution in the reaction, after reaction finishes, with 1: 1: 1～1: 10: 10 1M Na of 3ml
2CO
3, H
2O, 1M NaHCO
3Mixed solution neutralization, regulate pH to 7, with the 50mM NH of gained solution with 500ml～1000ml
4HCO
3Three freeze-drying of solution dialysis obtain the low molecular weight heparin that reduction end is an aldehyde radical; The above-mentioned reduction end of 1g is the low molecular weight heparin of aldehyde radical, be dissolved in the 0.2M phosphate buffer (pH7.0) of 10～100ml, the mercaptoethylmaine or the p-Mercaptoaniline that add 10ml 0.1～1M again, sodium cyanoborohydride catalyst with 1～2g, under 55～65 ℃ of temperature, reacted 2～10 hours, the solution that obtains dialysis freeze-drying obtains the low molecular weight heparin with sulfydryl; The golden nanometer particle of preparation fast detecting virus, the sodium borohydride or the natrium citricum reducing agent that add 5ml 0.01～0.1mM earlier in to 20ml 1～5mM chlorauric acid solution, after reacting 0.5～3 hour under 65～100 ℃ the temperature, the low molecular weight heparin that adds the above-mentioned band sulfydryl of 0.1～10g, stirring at normal temperature 0.5～2 hour, with the solution of gold nanoparticles that obtains with the centrifuge of 10000～30000r/min centrifugal after, Tris-HCl buffer solution (pH7.6) with the 10mM of 10～100ml dissolves again, the above-mentioned steps triplicate obtains heparin-modified gold nano particles solution.
Compare with other detection methods, the present invention has following advantage: at first prepared the low molecular weight heparin gold nano-particles modified of band sulfydryl, the step of synthesizing nano-particle is simple to operation, and cost is low, and good stability.And can be used for the detection of virus and protein, the present invention has expanded new direction in field of nano diagnosis.
Description of drawings
Fig. 1 is the ultraviolet absorpting spectrum of the low molecular weight heparin gold nano-particles modified of band sulfydryl
Fig. 2 is transmission electron microscope (TEM) collection of illustrative plates of the low molecular weight heparin gold nano-particles modified of band sulfydryl
The specific embodiment
Embodiment 1: reduction end is the preparation of the low molecular weight heparin of aldehyde radical
0.5M H with 1: 1～1: 20
2SO
4With 5.5M NaNO
2Solution is mixed with 5mlHNO
2Solution adds the heparin of 1g then, fully mix, 0～10 ℃ of reaction 0.5～4 hour down, in the course of reaction every solution of jolting in 5～10 seconds, after reaction finishes, with 1: 1: 1～1: 10: 10 1M Na of 3ml
2CO
3, H
2O, 1M NaHCO
3Mixed solution neutralization, regulate pH to 7, with the 50mMNH of gained solution with 500ml～1000ml
4HCO
3Three freeze-drying of solution dialysis obtain the low molecular weight heparin that reduction end is an aldehyde radical.
Embodiment 2: the preparation of the low molecular weight heparin of band sulfydryl
The reduction end of 1g is the low molecular weight heparin of aldehyde radical, be dissolved in the 0.2M phosphate buffer (pH7.0) of 10～100ml, the mercaptoethylmaine solution that adds 10ml 0.1～1M again after stirring, adds the sodium cyanoborohydride catalyst of 1～2g, under 55～65 ℃ of temperature, reacted 2～10 hours, after reaction finishes, solution centrifugal, get supernatant dialysis back freeze-drying, promptly get low molecular weight heparin sample with sulfydryl.
Embodiment 3: the preparation of the low molecular weight heparin of band sulfydryl
The reduction end of 1g is the low molecular weight heparin of aldehyde radical, be dissolved in the 0.2M phosphate buffer (pH7.0) of 10～100ml, the p-Mercaptoaniline solution that adds 10ml 0.1～1M again after stirring, adds the sodium cyanoborohydride catalyst of 1～2g, under 55～65 ℃ of temperature, reacted 2～10 hours, after reaction finishes, solution centrifugal, get supernatant dialysis back freeze-drying, promptly get low molecular weight heparin sample with sulfydryl.
Embodiment 4: the preparation of heparin-modified gold nano particles
The sodium borohydride reduction agent that in 20ml 1～5mM chlorauric acid solution, adds 5ml 0.01～0.1mM earlier, after reacting 0.5～3 hour under 65～100 ℃ the temperature, obtain inornate naked golden nanometer particle, the low molecular weight heparin that in solution, adds 0.1～10g band sulfydryl again, stirring at normal temperature 0.5～2 hour, with gained solution with the centrifuge of 10000～30000r/min centrifugal after, Tris-HCl buffer solution (pH7.6) with the 10mM of 10～100ml is resuspended with nano particle, more than operate triplicate, remove the heparin of not participating in reaction in the solution, obtain stable, the heparin-modified gold nano particles of good water solubility.
Embodiment 5: the preparation of heparin-modified gold nano particles
The natrium citricum reducing agent that in 20ml 1～5mM chlorauric acid solution, adds 5ml 0.01～0.1mM earlier, after reacting 0.5～3 hour under 65～100 ℃ the temperature, obtain inornate naked golden nanometer particle, the low molecular weight heparin that in solution, adds 0.1～10g band sulfydryl again, stirring at normal temperature 0.5～2 hour, with gained solution with the centrifuge of 10000～30000r/min centrifugal after, Tris-HCl buffer solution (pH7.6) with the 10mM of 10～100ml is resuspended with nano particle, more than operate triplicate, remove the heparin of not participating in reaction in the solution, obtain stable, the heparin-modified gold nano particles of good water solubility.
Claims (5)
1, a kind of method for preparing heparin-modified gold nano particles is characterized in that it being to be prepared by following process: be starting material with the heparin, at first use HNO
2A certain proportion of Na is used in solution degradation then
2CO
3, H
2O, NaHCO
3Mixed solution be neutralized to neutrality, at NH
4HCO
3After the dialysis, freeze-drying obtains the low molecular weight heparin that reduction end is an aldehyde radical in the solution; Reduction end is the low molecular weight heparin of aldehyde radical and mercaptoethylmaine or p-Mercaptoaniline reaction, makees catalyst with sodium cyanoborohydride, adds the freeze-drying of dialysing after the thermal response, obtains the low molecular weight heparin with sulfydryl; In sodium borohydride or natrium citricum are the solution of gold nanoparticles of reducing agent reduction, add the low molecular weight heparin of band sulfydryl, obtain the golden nanometer particle of low molecular weight heparin as trim.
2, reduction end according to claim 1 is the preparation of the low molecular weight heparin of aldehyde radical, it is characterized in that: described degraded solutions was with 1: 1～1: 20 0.5MH
2SO
4And 5.5MNaNO
2Solution is mixed with HNO
2Solution, the reaction time is 0.5～4 hour, and reaction temperature is 0～10 ℃, and the solution that is used to neutralize is 1: 1: 1～1: 10: 10 1MNa
2CO
3, H
2O, 1MNaHCO
3Mixed solution, the NH that is used to dialyse
4HCO
3Solution concentration is 50mM.
3, the preparation of the low molecular weight heparin of band sulfydryl according to claim 1, it is characterized in that: when described reduction end is that the consumption of the low molecular weight heparin of aldehyde radical is when being 1g, the solvent that is used for the terminal low molecular weight heparin for aldehyde radical of dissolving and reducing is the phosphate buffer (pH7.0) of the 0.2M of 1～100ml, the consumption of mercaptoethylmaine or p-Mercaptoaniline is 0.1～1M, the consumption of described reaction system catalyst sodium cyanoborohydride is 1～2g, reaction time is 2～10 hours, and reaction temperature is 55～65 ℃.
4, the preparation of heparin-modified gold nano particles according to claim 1, it is characterized in that: the concentration of the amount of substance of described chlorauric acid solution is 1～5mM, the consumption of described borane reducing agent sodium hydride or natrium citricum is 0.01～0.1mM, the initial concentration of the low molecular weight heparin of described band sulfydryl is 0.1～10g, reaction time is 0.5～3 hour, and reaction temperature is 65～100 ℃.
5, a kind of method for preparing heparin-modified gold nano particles is characterized in that concrete steps are as follows: the heparin of 1g, and with 1: 1～1: 20 0.5M H
2SO
4With 5.5M NaNO
2Solution is mixed with 5mlHNO
2Solution degradation was reacted 0.5～4 hour down at 0～10 ℃, took normal jolting solution in the reaction, after reaction finishes, with 1: 1: 1～1: 10: 10 1M Na of 3ml
2CO
3, H
2O, 1M NaHCO
3Mixed solution neutralization, regulate pH to 7, with the 50mM NH of gained solution with 500ml～1000ml
4HCO
3Three freeze-drying of solution dialysis obtain the low molecular weight heparin that reduction end is an aldehyde radical; The above-mentioned reduction end of 1g is the low molecular weight heparin of aldehyde radical, be dissolved in the 0.2M phosphate buffer (pH7.0) of 10～100ml, the mercaptoethylmaine or the p-Mercaptoaniline that add 10ml 0.1～1M again, sodium cyanoborohydride catalyst with 1～2g, under 55～65 ℃ of temperature, reacted 2～10 hours, the solution that obtains dialysis freeze-drying obtains the low molecular weight heparin with sulfydryl; The golden nanometer particle of preparation fast detecting virus, the sodium borohydride or the natrium citricum reducing agent that add 5ml 0.01～0.1mM earlier in to 20ml 1～5mM chlorauric acid solution, after reacting 0.5～3 hour under 65～100 ℃ the temperature, the low molecular weight heparin that adds the above-mentioned band sulfydryl of 0.1～10g, stirring at normal temperature 0.5～2 hour, with the solution of gold nanoparticles that obtains with the centrifuge of 10000～30000r/min centrifugal after, Tris-HCl buffer solution (pH7.6) with the 10mM of 10～100ml dissolves again, the above-mentioned steps triplicate obtains heparin-modified gold nano particles solution.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200910024843 CN101491835B (en) | 2009-02-27 | 2009-02-27 | Preparation method of heparin modified gold nano-particles |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200910024843 CN101491835B (en) | 2009-02-27 | 2009-02-27 | Preparation method of heparin modified gold nano-particles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101491835A true CN101491835A (en) | 2009-07-29 |
| CN101491835B CN101491835B (en) | 2013-07-17 |
Family
ID=40922724
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200910024843 Expired - Fee Related CN101491835B (en) | 2009-02-27 | 2009-02-27 | Preparation method of heparin modified gold nano-particles |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101491835B (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102049226A (en) * | 2010-11-16 | 2011-05-11 | 中国烟草总公司郑州烟草研究院 | Method for preparing TMV template-based nano-gold material |
| CN102435571A (en) * | 2011-09-16 | 2012-05-02 | 东华大学 | Method for detecting heparin content with polyethyleneimine-stabilized gold nanoparticle |
| US8834932B2 (en) | 2011-12-19 | 2014-09-16 | Industry Technology Research Institute | Anticoagulant-conjugated carbon nanocapsule, antithrombotic agent containing thereof |
| CN108403704A (en) * | 2018-05-31 | 2018-08-17 | 江南大学 | Heparin disaccharides is grafted the purposes of sulphation polymethyl acyl ethanol amine |
| CN110596065A (en) * | 2019-09-25 | 2019-12-20 | 福建医科大学 | Acid phosphatase detection method based on cysteamine-N-acetyl-L-cysteine-gold nanocluster fluorescent material |
| CN110672567A (en) * | 2019-09-26 | 2020-01-10 | 南通大学 | Low molecular weight heparin gold nano material and application thereof in heparanase detection |
| CN111975010A (en) * | 2019-05-21 | 2020-11-24 | 中国药科大学 | Preparation of gold nanoparticles based on D-arabinose reduction |
| CN112692297A (en) * | 2019-10-07 | 2021-04-23 | 福建医科大学 | Osmium nano particle with anticoagulation effect and oxidase activity |
| CN112779219A (en) * | 2019-11-11 | 2021-05-11 | 百脉迪生物科技(苏州)有限公司 | Method for promoting neural differentiation of stem cells and differentiation culture medium |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080044657A1 (en) * | 2006-08-21 | 2008-02-21 | Kyoungja Woo | Single nanoparticle containing organic-inorganic composite material and method of preparing the same |
| CN101245387A (en) * | 2008-01-22 | 2008-08-20 | 中国科学院上海应用物理研究所 | Nano-gold signal probe for DNA detection, production method and method for detecting DNA |
-
2009
- 2009-02-27 CN CN 200910024843 patent/CN101491835B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080044657A1 (en) * | 2006-08-21 | 2008-02-21 | Kyoungja Woo | Single nanoparticle containing organic-inorganic composite material and method of preparing the same |
| CN101245387A (en) * | 2008-01-22 | 2008-08-20 | 中国科学院上海应用物理研究所 | Nano-gold signal probe for DNA detection, production method and method for detecting DNA |
Non-Patent Citations (1)
| Title |
|---|
| 郭艳丽等: ""肝素稳定的金纳米微粒自组装薄膜的光谱研究"", 《光谱学与光谱分析》 * |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102049226A (en) * | 2010-11-16 | 2011-05-11 | 中国烟草总公司郑州烟草研究院 | Method for preparing TMV template-based nano-gold material |
| CN102435571A (en) * | 2011-09-16 | 2012-05-02 | 东华大学 | Method for detecting heparin content with polyethyleneimine-stabilized gold nanoparticle |
| CN102435571B (en) * | 2011-09-16 | 2014-07-23 | 东华大学 | Method for detecting heparin content with polyethyleneimine-stabilized gold nanoparticle |
| US8834932B2 (en) | 2011-12-19 | 2014-09-16 | Industry Technology Research Institute | Anticoagulant-conjugated carbon nanocapsule, antithrombotic agent containing thereof |
| CN108403704A (en) * | 2018-05-31 | 2018-08-17 | 江南大学 | Heparin disaccharides is grafted the purposes of sulphation polymethyl acyl ethanol amine |
| CN111975010A (en) * | 2019-05-21 | 2020-11-24 | 中国药科大学 | Preparation of gold nanoparticles based on D-arabinose reduction |
| CN110596065B (en) * | 2019-09-25 | 2021-10-15 | 福建医科大学 | Acid phosphatase detection method based on cysteamine-N-acetyl-L-cysteine-gold nanocluster fluorescent material |
| CN110596065A (en) * | 2019-09-25 | 2019-12-20 | 福建医科大学 | Acid phosphatase detection method based on cysteamine-N-acetyl-L-cysteine-gold nanocluster fluorescent material |
| CN110672567A (en) * | 2019-09-26 | 2020-01-10 | 南通大学 | Low molecular weight heparin gold nano material and application thereof in heparanase detection |
| CN110672567B (en) * | 2019-09-26 | 2022-01-11 | 南通大学 | Low molecular weight heparin gold nano material and application thereof in heparanase detection |
| CN112692297A (en) * | 2019-10-07 | 2021-04-23 | 福建医科大学 | Osmium nano particle with anticoagulation effect and oxidase activity |
| CN112779219A (en) * | 2019-11-11 | 2021-05-11 | 百脉迪生物科技(苏州)有限公司 | Method for promoting neural differentiation of stem cells and differentiation culture medium |
| CN112779219B (en) * | 2019-11-11 | 2023-03-28 | 百脉迪生物科技(苏州)有限公司 | Method for promoting neural differentiation of stem cells and differentiation culture medium |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101491835B (en) | 2013-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101491835B (en) | Preparation method of heparin modified gold nano-particles | |
| Liu et al. | A photoelectrochemical aptasensor based on a 3D flower-like TiO2-MoS2-gold nanoparticle heterostructure for detection of kanamycin | |
| Yang et al. | Hydrogen-bond-mediated in situ fabrication of AgNPs/Agar/PAN electrospun nanofibers as reproducible SERS substrates | |
| Ou et al. | Ion-driven photoluminescence modulation of quasi-two-dimensional MoS2 nanoflakes for applications in biological systems | |
| Kim et al. | Graphene oxide sheath on Ag nanoparticle/graphene hybrid films as an antioxidative coating and enhancer of surface-enhanced Raman scattering | |
| Hu et al. | In situ synthesis and characterization of multiwalled carbon nanotube/Au nanoparticle composite materials | |
| Wang et al. | Facile fabrication of gold nanoparticles-poly (vinyl alcohol) electrospun water-stable nanofibrous mats: efficient substrate materials for biosensors | |
| Zhang et al. | One-step synthesis of large-scale graphene film doped with gold nanoparticles at liquid–air interface for electrochemistry and Raman detection applications | |
| Wu et al. | Platinum nanoparticle modified polyaniline-functionalized boron nitride nanotubes for amperometric glucose enzyme biosensor | |
| Zhang et al. | Cerium oxide–graphene as the matrix for cholesterol sensor | |
| Xu et al. | Size-dependent Mie’s scattering effect on TiO2 spheres for the superior photoactivity of H2 evolution | |
| Cai et al. | Porous gold-nanoparticle− CaCO3 hybrid material: preparation, characterization, and application for horseradish peroxidase assembly and direct electrochemistry | |
| Silvestri et al. | Production of electrospun nanofibers based on graphene oxide/gum Arabic | |
| CN100434167C (en) | Method for preparing carbon nanometer material carried with noble metal(S) | |
| CN102965101B (en) | Material with surface-enhancement Raman scattering performance and catalytic activity, preparation method and application thereof | |
| Pant et al. | One-pot synthesis of CdS sensitized TiO2 decorated reduced graphene oxide nanosheets for the hydrolysis of ammonia-borane and the effective removal of organic pollutant from water | |
| CN101811665B (en) | Method for preparing metal nano-particle modified polysaccharide wrapped carbon nano tube | |
| Song et al. | Electrospun nanofibrous materials: A versatile platform for enzyme mimicking and their sensing applications | |
| CN102674334A (en) | Preparation method of graphene with nano ferroferric oxide precipitated on surface | |
| Zhang et al. | Pt/ZnO@ C nanocable with dual-enhanced photocatalytic performance and superior photostability | |
| CN103172051A (en) | Water-soluble carbon quantum dot and preparation method thereof | |
| Wang et al. | Facile synthesis of trilaminar core-shell Ag@ C@ Ag nanospheres and their application for H2O2 detection | |
| Liu et al. | Superwettable microwell arrays constructed by photocatalysis of silver-doped-ZnO nanorods for ultrasensitive and high-throughput electroanalysis of glutathione in hela cells | |
| Konował et al. | Functionalization of organically modified silica with gold nanoparticles in the presence of lignosulfonate | |
| Mou et al. | Promoting nanozyme cascade bioplatform by ZIF-derived N-doped porous carbon nanosheet-based protein/bimetallic nanoparticles for tandem catalysis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130717 Termination date: 20160227 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |